Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Royal London Asset Management Ltd.

Royal London Asset Management Ltd. reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 346,451 shares of the medical equipment provider’s stock after selling 1,970 shares during the period. Royal London Asset Management Ltd.’s holdings in Intuitive Surgical were worth $180,834,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. State Street Corp lifted its position in Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after buying an additional 210,363 shares in the last quarter. FMR LLC raised its stake in shares of Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after acquiring an additional 838,793 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 1.9% during the 3rd quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock valued at $3,677,194,000 after acquiring an additional 143,440 shares in the last quarter. Fisher Asset Management LLC boosted its position in Intuitive Surgical by 1.8% during the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock worth $2,541,356,000 after purchasing an additional 86,488 shares during the period. Finally, Wellington Management Group LLP increased its holdings in Intuitive Surgical by 1.7% in the 3rd quarter. Wellington Management Group LLP now owns 3,115,024 shares of the medical equipment provider’s stock valued at $1,530,318,000 after purchasing an additional 53,383 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $492.06 on Thursday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The company has a fifty day moving average price of $564.39 and a two-hundred day moving average price of $531.62. The company has a market cap of $175.26 billion, a PE ratio of 76.76, a P/E/G ratio of 5.85 and a beta of 1.43.

Insider Activity

In related news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 33,754 shares of company stock valued at $17,691,621. Company insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on ISRG shares. Evercore ISI boosted their price objective on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Barclays upped their price target on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Jefferies Financial Group lifted their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Erste Group Bank downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday. Finally, BTIG Research lifted their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $611.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.